Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

H3K4 Methylation in β-cells prevents transcriptional downregulation and variance associated with type 2 diabetes.

ABSTRACT: H3K4 Methylation in β-cells prevents transcriptional downregulation and variance associated with type 2 diabetes.

PROVIDER: PRJNA754029 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

H3K4 Methylation in β-cells prevents transcriptional downregulation and variance associated with type 2 diabetes [RNA-seq]

Project description:H3K4 Methylation in β-cells prevents transcriptional downregulation and variance associated with type 2 diabetes [RNA-seq]

| PRJNA754034 | ENA

H3K4 Methylation in β-cells prevents transcriptional downregulation and variance associated with type 2 diabetes [ChIP-seq]

Project description:H3K4 Methylation in β-cells prevents transcriptional downregulation and variance associated with type 2 diabetes [ChIP-seq]

| PRJNA754033 | ENA

H3K4 Methylation in β-cells prevents transcriptional downregulation and variance associated with type 2 diabetes [RNA-seq]

Project description:Insufficient insulin release by β-cells is the primary etiology in type 2 diabetes (T2D) and coincides with impaired expression of genes essential to β-cell function, but drivers of gene expression dysregulation are not well resolved. We find that H3K4me3 peak breadth correlates with gene expression dysregulation in T2D. Using an adult β-cell Dpy30-KO mouse model, we show that global reduction of H3K4 methylation causes downregulation of genes also downregulated in T2D. Reduction of H3K4 methylation increases transcriptional entropy and reduces insulin production and glucose-responsiveness. Depletion of H3K4 methylation causes global dilution of epigenetic complexity but does not generally reduce gene expression – instead, genes related to β-cell function and/or in particular chromatin environments are specifically affected. Our data further suggests that promoter-associated H3K4me1 is sufficient to maintain expression in the absence of H3K4me3. These data implicate dysregulation of H3K4 methylation in destabilizing gene expression and contributing to β-cell dysfunction in T2D.

2022-08-11 | GSE181950 | GEO

H3K4 Methylation in β-cells prevents transcriptional downregulation and variance associated with type 2 diabetes [ChIP-seq]

2022-08-11 | GSE181949 | GEO

H3K4 Methylation in β-cells prevents transcriptional downregulation and variance associated with type 2 diabetes.

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-08-11 | GSE181951 | GEO

Targeted elimination of senescent beta cells prevents Type 1 Diabetes

Project description:Targeted elimination of senescent beta cells prevents Type 1 Diabetes

| PRJNA483137 | ENA

Early senescence-induced immunosuppressive β-cell secretome prevents type 1 diabetes

Project description:Early senescence-induced immunosuppressive β-cell secretome prevents type 1 diabetes

| PRJNA1001807 | ENA